原料藥(API)

原料藥(API)

53 個產品

原料藥與多肽,純度 ≥99%,經審核合格的合作工廠供應。可隨批提供 COA 與 MSDS。

結構圖CAS 編號產品名稱細分類含量
Abemaciclib,LY2835219 structure1231929-97-7Abemaciclib,LY2835219抗腫瘤原料藥99%
Acalabrutinib, ACP-196 CAS NO.:1420477-60-6 structure1420477-60-6Acalabrutinib, ACP-196 CAS NO.:1420477-60-6抗腫瘤原料藥99%
Afatinib Dimaleate structure850140-73-7Afatinib Dimaleate抗腫瘤原料藥99%
Alectinib Hydrochloride structure1256589-74-8Alectinib Hydrochloride抗腫瘤原料藥99%
Axitinib structure319460-85-0Axitinib抗腫瘤原料藥99%
Cabozantinib Malate structure1140909-48-3Cabozantinib Malate抗腫瘤原料藥99%
Crizotinib structure877399-52-5Crizotinib抗腫瘤原料藥99%
Dacomitinib structure1110813-31-4Dacomitinib抗腫瘤原料藥99%
Galunisertib structure700874-72-2Galunisertib抗腫瘤原料藥99%
Ibrutinib structure936563-96-1Ibrutinib抗腫瘤原料藥99%
Larotrectinib Sulfate structure1223405-08-0Larotrectinib Sulfate抗腫瘤原料藥99%
Lenvatinib Mesylate structure857890-39-2Lenvatinib Mesylate抗腫瘤原料藥99%
Lorlatinib structure1454846-35-5Lorlatinib抗腫瘤原料藥99%
Neratinib Maleate structure915942-22-2Neratinib Maleate抗腫瘤原料藥99%
Nintedanib Ethanesulfonate structure656247-18-6Nintedanib Ethanesulfonate抗腫瘤原料藥99%
Niraparib structure1038915-60-4Niraparib抗腫瘤原料藥99%
Niraparib Tosylate Monohydrate structure1613220-15-7Niraparib Tosylate Monohydrate抗腫瘤原料藥99%
Olaparib structure763113-22-0Olaparib抗腫瘤原料藥99%
Osimertinib Mesylate structure1421373-66-1Osimertinib Mesylate抗腫瘤原料藥99%
Pazopanib Hydrochloride structure635702-64-6Pazopanib Hydrochloride抗腫瘤原料藥99%
Ponatinib Hydrochloride structure1114544-31-8Ponatinib Hydrochloride抗腫瘤原料藥99%
Poziotinib structure1092364-38-9Poziotinib抗腫瘤原料藥99%
Regorafenib Hydrate structure1019206-88-2Regorafenib Hydrate抗腫瘤原料藥99%
Ribociclib Succinate structure1374639-75-4Ribociclib Succinate抗腫瘤原料藥99%
Ruxolitinib Phosphate structure1092939-17-7Ruxolitinib Phosphate抗腫瘤原料藥99%
Temozolomide structure85622-93-1Temozolomide抗腫瘤原料藥99%
Vandetanib structure443913-73-3Vandetanib抗腫瘤原料藥99%
Veliparib structure912444-00-9Veliparib抗腫瘤原料藥99%
Veliparib dihydrochloride structure912445-05-7Veliparib dihydrochloride抗腫瘤原料藥99%
Vemurafenib structure918504-65-1Vemurafenib抗腫瘤原料藥99%
Alogliptin benzoate structure850649-62-6Alogliptin benzoate抗糖尿病原料藥99%
Dapagliflozin structure461432-26-8Dapagliflozin抗糖尿病原料藥99%
Empagliflozin structure864070-44-0Empagliflozin抗糖尿病原料藥99%
Ertugliflozin L-Pyroglutamic Acid structure1210344-83-4Ertugliflozin L-Pyroglutamic Acid抗糖尿病原料藥99%
Linagliptin structure668270-12-0Linagliptin抗糖尿病原料藥99%
Sotagliflozin structure1018899-04-1Sotagliflozin抗糖尿病原料藥99%
Trelagliptin Succinate structure1029877-94-8Trelagliptin Succinate抗糖尿病原料藥99%
Glecaprevir structure1365970-03-1Glecaprevir抗肝炎原料藥99%
Obeticholic Acid structure459789-99-2Obeticholic Acid抗肝炎原料藥99%
Pibrentasvir structure1353900-92-1Pibrentasvir抗肝炎原料藥99%
Simeprevir Sodium structure1241946-89-3Simeprevir Sodium抗肝炎原料藥99%
Sofosbuvir structure1190307-88-0Sofosbuvir抗肝炎原料藥99%
Tenofovir Alafenamide Fumarate structure1392275-56-7Tenofovir Alafenamide Fumarate抗肝炎原料藥99%
Velpatasvir structure1377049-84-7Velpatasvir抗肝炎原料藥99%
Baricitinib structure1187594-09-7Baricitinib抗風濕原料藥99%
Methotrexate structure59-05-2Methotrexate抗風濕原料藥99%
Tofacitinib Citrate structure540737-29-9Tofacitinib Citrate抗風濕原料藥99%
Upadacitinib structure1310726-60-3Upadacitinib抗風濕原料藥99%
Atosiban Acetate structure90779-69-4Atosiban Acetate多肽類99%
Glutathione structure70-18-8Glutathione多肽類99%
Octreotide Acetate structure83150-76-9Octreotide Acetate多肽類99%
Plecanatide structure467426-54-6Plecanatide多肽類99%
Terlipressin Acetate structure14636-12-5Terlipressin Acetate多肽類99%
品質與文件——每批隨附 COA(HPLC 純度與雜質譜);含手性中心的品種提供手性 HPLC 數據;可按需提供 ICH Q3C/Q3D 口徑的殘留溶劑與元素雜質數據;首批貨物附 NMR 與 MS 結構確證;SDS 按目標市場語言與 GHS 分類提供。

沒有找到需要的原料藥?我們可按需調取更廣的中國原料藥與多肽資源——提供 CAS 號或 INN 名,我們會確認可供性、文件與交期。

提交需求